Hepatitis B vaccine in infants from an e
β
B. Yvonnet; P. Coursaget; J. Chotard; M. Sarr; R. Ndoye; J. P. Chiron; I. Diop-M
π
Article
π
1987
π
John Wiley and Sons
π
English
β 395 KB
Persistence of anti-HBs in 156 Senegalese infants immunized with hepatitis B vaccine was studied for periods ranging from 2 to 6 years after booster dose administration. Six years after the booster dose, 90.4% of the infants had detectable anti-HBs antibodies, with 78.1% having titers higher than 10